Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat

Cardiovascular Toxicology

Volumn 16, Issue 2, 2016, Pages 147-155

  Mnafgui, Kais ^a,b   Hajji, Raouf ^b   Derbali, Fatma ^b   Khlif, Ines ^a   Kraiem, Ftouma ^c   Ellefi, Hedi ^d   Elfeki, Abdelfattah ^a   Allouche, Noureddine ^a   Gharsallah, Neji ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b Faculté de Médecine de Sousse   (Tunisia)

^c Centre Hospitalier Intercommunal Robert Ballanger ^*  (Tunisia)

^d Centre Hospitalier Robert Ballanger CHRB   (France)

Author keywords

ACE; ECG; Hydroxytyrosol; Myocardial infarction; Troponin T

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYTYROSOL; ISOPRENALINE; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL LIPASE; TROPONIN T; 3,4-DIHYDROXYPHENYLETHANOL; CARDIOTONIC AGENT; PHENETHYL ALCOHOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG ACTIVITY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; GRAVIMETRY; HEART HEMODYNAMICS; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; ST SEGMENT ELEVATION; TREATMENT DURATION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 84961181219     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-015-9323-1     Document Type: Article

References (30)

1. Aronow, W. S. (2006). Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiology in Review,14, 108–124.
2. White, M. Y., Edwards, A. G., Cordwell, S. J., & Van Eyk, J. E. (2008). Mitochondria: A mirror into cellular dysfunction in heart disease. Proteomics-Clinical Applications,2, 845–861.
3. Upaganlawar, A., Gandhi, H., & Balaraman, R. (2011). Isoproterenol induced myocardial infarction: Protective role of natural products. Journal of Pharmacolgical Toxicology,6, 1–17.
4. Fito, M. De, La Torre, R., Farre-Albaladejo, M., Khymenetz, O., Marrugat, J., & Covas, M. (2007). Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: A review. Annali dell’Istituto Superiore di Sanità,43, 375.
5. Hamden, K., Allouche, N., Damak, M., & Elfeki, A. (2009). Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats. Chemical Biological Interaction,180, 421–432.
6. Lee, O. H., & Lee, B. Y. (2010). Antioxidant and antimicrobial activities of individual and combined phenolics in Olea europaea leaf extract. Bioresource Technology,101, 3751–3754.
7. Queenthy, S. S., & John, B. (2013). Diosmin exhibits anti-hyperlipidemic effects in isoproterenol induced myocardial infracted rats. European Journal of Pharmacology,718, 213–218.
8. Friedewal, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry,18, 499–502.
9. Allouche, N., Fki, I., & Sayadi, S. (2004). Toward a high yield recovery of antioxidants and purified hydroxytyrosol from olive mill wastewaters. Journal of Agriculture and Food Chemistry,52, 267–273.
10. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C. L., Sanchez-Rovira, P., & Ramirez-Tortosa, M. C. (2010). Hydroxytyrosol: From laboratory investigations to future clinical trials. Nutrition Reviews,68, 191–206.
11. O’Dowd, Y., Driss, F., Dang, P. M., Elbim, C., Gougerot-Pocidalo, M. A., Pasquier, C., et al. (2004). Antioxidant effect of hydroxytyrosol, a polyphenol from olive oil: Scavenging of hydrogen peroxide but not superoxide anion produced by human neutrophils. Biochemical Pharmacology,68, 2003–2008.
12. González-Correa, J. A., Navas, M. D., Lopez-Villodres, J. A., Trujillo, M., Espartero, J. L., & De La Cruz, J. P. (2008). Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neuroscience Letters,446, 143–146.
13. Vázquez-Velasco, M. Esperanza, Díaz, L., Lucas, R., Gómez-Martínez, S., Bastida, S., Marcos, A., & Sánchez-Muniz, F. J. (2011). Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors. British Journal of Nutrition,105, 1448–1452.
14. Cabrerizo, S. La, Cruz, D., Pedro, J., López-Villodres, J. A., Muñoz-Marín, J., Guerrero, A., & González-Correa, J. A. (2013). Role of the inhibition of oxidative stress and inflammatory mediators in the neuroprotective effects of hydroxytyrosol in rat brain slices subjected to hypoxia reoxygenation. Journal of Nutritional Biochemistry,24, 2152–2157.
15. Kannan, M. M., & Quine, S. D. (2011). Ellagic acid ameliorates isoproterenol induced oxidative stress: Evidence from electrocardiological, biochemical and histological study. European Journal of Pharmacology,659, 45–52.
16. Kannan, M. M., & Quine, D. S. (2013). Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism,62, 52–61.
17. Whalen, E. J., & Lewis, S. J. (1999). In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac β1-or β2-adrenoceptors. European Journal of Pharmacology,382, 207–210.
18. Granados-Principal, S., El-Azem, N., Pamplona, R., Ramirez-Tortosa, C., Pulido-Moran, M., Vera-Ramirez, L., et al. (2014). Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer. Biochemical Pharmacology,90, 25–33.
19. O’Brien, P. J., Smith, D. C., Knechtel, T. J., Marchak, M. A., Pruimboom-Brees, I., Brees, D. J., et al. (2006). Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Laboratory Animals,40, 153–171.
20. Evran, B., Karpuzoğlu, H., Develi, S., Kalaz, E. B., Soluk-Tekkeşin, M., Olgaç, V., & Uysal, M. (2014). Effects of carnosine on prooxidant–antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction. Pharmacological Reports,66, 81–86.
21. Radhiga, T., Rajamanickam, C., Sundaresan, A., Ezhumalai, M., & Pugalendi, K. V. (2012). Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol induced myocardial infarction. Biochimie,94, 1135–1142.
22. Kumaran, K. S., & Prince, P. S. M. (2010). Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study. Metabolism-Clinical and Experimental,59, 1172–1180.
23. Leroith, D. (2007). Dyslipidemia and glucose dysregulation in over weight and obese patients. Clinical Cornerstone,8, 38–52.
24. Mnafgui, K., Derbali, A., Sayadi, S., Gharsallah, N., Elfeki, A., & Allouche, N. (2014). Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet-induced obese rats. Journal of Food Science and Technology,. doi:10.1007/s13197-014-1488-2.
25. Fki, I., Sahnoun, Z., & Sayadi, S. (2007). Hypocholesterolemic effects of phenolic extracts and purified hydroxytyrosol recovered from olive mill wastewater in rats fed a cholesterol-rich diet. Journal of Agriculture and Food Chemistry,55, 624–631.
26. Jemai, H. El, Feki, A., & Sayadi, S. (2009). Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. Journal of Agriculture and Food Chemistry,57, 8798–8804.
27. Schieffer, B., Wirger, A., Meybrunn, M., Seitz, S., Holtz, J., Riede, U. N., & Drexler, H. (1994). Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation,89, 2273–2282.
28. Borghi, C., Bacchelli, S., Esposti, D. D., & Ambrosioni, E. (2006). Effects of early angiotensin-converting enzyme inhibition in patients with non–ST-elevation acute anterior myocardial infarction. American Heart Journal,152, 470–477.
29. Teyssedou, A. (2007). LES IEC dans le post-infarctus: gros plan sur le zofénopril. Annales de Cardiologie et d Angéiologie,56, 137–144.
30. Lindpaintner, K., Lu, W., Niedermayer, N., Schieffer, B., Just, H., Ganten, D., & Drexler, H. (1993). Selective activation of cardiac angiotensinogen expression in postinfarction ventricular remodeling in the rat. Journal of Molecular and Cellular Cardiology,25, 133–145.